glp-1 in heart failure Impact of receptor agonists on cardiovascular outcomes with preserved ejection fraction (HFpEF): systematic review and meta-analysis | Clinical Research in Cardiology Beyond weight loss: the potential

Nihon Seikeigeka Gakkai Zasshi 68 , 10561067 (1994)

While their mechanisms (BDNF upregulation, synaptogenesis) do not directly overlap with monoamine reuptake inhibition, the lack of safety data makes concurrent use inadvisable without baseline cardiovascular assessment and ongoing monitoring

A key part of the formulation of this beverage influences how full you feel after eating

The regulatory landscape for compounded GLP-1 medications continues to evolve

GHK-Cu is a human copper-binding peptide proven to confer a host of benefits related to healing, tissue regeneration, and skin, hair, and nail health

The FDA touted this new crackdown on pharma ads as closing a loophole that has allowed pharmas to promote their medicines without disclosing the risks